However, the trial ended prematurely as investigators did not meet their sample size, so the funding was discontinued.
How? Why? This kind of study should be trivially easy to complete. The medication is already on the market, generics are super cheap, administration is super simple and non-invasive and I'd guess there are plenty of women suffering from PMS. That sounds like the kind of study that a grad student could pull off on a DIY budget.
According to Google, generics are ~€0.50 per dose and they administered a single dose per patient. Let's say placebos cost the same as the generics, then the cost for these 25 participants was less than €15.